Abstract
Introduction

With respect to gene control and regulation, a great number of inducer-responsive elements have been identified and characterized within the 5Ј-flanking regions of the mouse, rat and human heme oxygenase-1 (HO-1). In the past decades, substantial progress has been made in our understanding of the regulation and function in the importance of HO-1 and its by-products, e.g. iron and endogenous CO, in the recovery of cardiac injury caused by ischemia
.
In our previous studies, we observed a reduction in HO-1 mRNA and protein expression causing decreased enzyme activity leading ultimately to poor recovery of the ischemic/reperfused fibrillated myocardium [13, 14] . To conclusively demonstrate whether HO-1 plays a critical role in the recovery of post-ischemic myocardium, we generated HO-1 transgenic mice (Tg) . We . [15] [16] [17] 
suggested that the vulnerability of HO-1 Tg to reduce the incidence of ventricular fibrillation (VF), attenuation of infarct size and improved recovery of post-ischemic function during ischemia/reperfusion injury would be related to HO-1 protein expression and its byproducts including the endogenous CO or iron. We also speculated that HO-1 signalling and protein expression would play an essential role in the improvement post-ischemic cardiac aortic flow (AF), coronary flow (CF), aortic pressure (AOP), the first derivative of AOP (AOPdp/dt), myocardial ion contents including Na
Various mechanisms have been proposed to explain the post-ischemic recovery and the causes of arrhythmias, but relatively little attention has been paid, to our knowledge, in order to clarify the mechanism(s) of VF at a gene expression level in ischemic/reperfused hearts. For instance, the long QT syndrome and idiopathic VF, as known until now, are cardiac disorders based on genetic mutation of potassium channels and cause sudden cardiac death from ventricular arrhythmias
. The aim of our present study was to generate and use HO-1 Tg to directly analyse the impact and role of HO-1 on post-ischemic recovery in the myocardium. In some additional studies, we made attempt to estimate the incidence of reperfusion-induced VF and infarct size in HO-1 Tg mouse heart in comparison with HO-1 knockout (KO)
Ϫ/Ϫ and wild-type mouse myocardium. We believe that the present study provides novel insights into the function of HO-1 and its contribution to the recovery of post-ischemic cardiac function and reduction of arrhythmias in the heart.
Methods
Transgenic mice
Tg were generated as described by Araujo et al. [9] . In brief, CFY mouse eggs were injected with 52 kb rat HO-1 construct containing 27.7 [25] . Proteins were determined by the method of Lowry et al. [26] , in microsomal fractions.
kb of the 5Ј upstream region, 8.3 kb of HO-1 gene and 16 kb of the 3Ј downstream region. Cloning was carried out by PCR of rat genomic P1 library with two sets of PCR primers corresponding to the first exon (5Ј-GCT-TCG-GTG-GGT-TAT-CTG-CCG-TTA-T-3Ј and 5Ј-CAG-TCT-TAC-AGG-CGG-GGA-ATG-TGA-G-3Ј), and the fifth exon of rat HO-1 gene (5Ј-GAG-ACG-CCC-CGA-GGA-AAA-TCC-CAG-AT-3Ј and 5Ј-CCC-AAG-AAA-AGA-GAG-CCA-GGC-AAG-AT-3Ј
Measurement of HO activity
Measurement of CO
Tissue CO content using gas chromatography was detected as described by Cook et al. [27] . [29, 30] and central nervous system [31] .
Statistics
The (Fig. 2B, lower part) . (Fig. 2C) Fig. 2A, lower part) or Western blot (Fig. 2B, lower (Fig. 2C) . Thus, the differences in HO enzyme activities (Fig. 2C) (Fig. 3B,  chromatogram) , a substantial increase in CO production was observed in comparison with the NTg myocardium (Fig. 3A, chromatogram) . However, the endogenous production of CO in the HO-1 Tg myocardium treated with SnPPIX was detected at relatively low level. (Fig. 3C, chromatogram) . Figure 4 shows representative pictures of infarct size (Fig. 4A , lower part, to the right) and immunohistochemical staining of HO-1 (Fig. 4A, lower (Fig. 4A) . However, in the HO-1 KO hearts, the infarct size was significantly increased to 47 Ϯ 5% (*P Ͻ 0.05) in comparison with NTg group (Fig. 4A) .
HO enzyme activities were also measured in the LV, RV and S obtained from NTg and Tg mice (Fig. 2C). The results show that HO activities were significantly increased in samples obtained from the LV, RV and S of Tg mouse hearts in comparison with NTg values
Figure 3 depicts representative curves of endogenous CO production detected by GC in NTg, Tg and Tg SnPPIX treated myocardium subjected to 20 min. ischemia followed by 120 min. of reperfusion. It is shown that in HO-1 Tg hearts subjected to 20 min. of ischemia followed by 120 min. of reperfusion
In addition, Figure 4A shows the representative immunohistochemical localization of HO-1 (Fig. 4A, lower part - (Fig. 4A,  lower part -to the left) . [32, 33] , heart failure [34] [35] [36] , organ transplantation [9, 37] and arrhythmias [38, 39] [40] [41] [42] and the production of growth factors to promote angiogenesis [43] [44] [45] [46] [47] for the treatment of peripheral vascular disease and myocardial ischemia.
Figure 4 also shows the incidence (%) of reperfusion-induced VF (Fig. 4B) as total (sustained and non-sustained) and sustained VF in NTg, Tg and KO mouse groups. The incidence of reperfusion-induced total and sustained VF (Fig. 4B) was significantly reduced from their NTg control values of 92% and 83% to 25%
Discussion
Myocardial ischemia/reperfusion-induced damage is a major cause of morbidity and mortality in the industrialized society, and considerable efforts have been made to target interventional therapies for this condition. In recent years, the concept of the modification in various gene expressions or repressions has emerged as new mechanisms and therapeutic tools for the induction of protection in ischemic/reperfused tissues. It is now also relatively well accepted that many human vascular diseases such as hypertension
In our previous studies, we found a substantial reduction in the expression of HO-1 mRNA and its protein with a causative reduction in the HO-1 enzyme activity in fibrillated ischemic/reperfused rat myocardium [13] . Moreover, we have shown that, in this respect, no difference exists between non-diabetic and diabetic heart [48] . Furthermore, HO-1 KO mouse hearts displayed a reduced left ventricular function after ischemia/reperfusion [14] . [50] . Indeed, a moderate increase in cAMP content could lead to arrhythmogenesis and development of various arrhythmias by elevating cytosolic calcium levels [51] in the ischemic and post-ischemic myocardium. It is of interest to note that multiple increases in cGMP levels could mask and interfere with the arrhythmogenic effects of cAMP leading to the suppression of reperfusion-induced VF in the myocardium [50] 
